Bupropion SR and contingency management for adolescent smoking cessation.

@article{Gray2011BupropionSA,
  title={Bupropion SR and contingency management for adolescent smoking cessation.},
  author={Kevin M Gray and Matthew J Carpenter and Nathaniel L. Baker and Karen J. Hartwell and A. Lee Lewis and D Walter Hiott and Deborah Deas and Himanshu P. Upadhyaya},
  journal={Journal of substance abuse treatment},
  year={2011},
  volume={40 1},
  pages={
          77-86
        }
}
There is a significant need for evidence-based treatments for adolescent smoking cessation. Prior research, although limited, has suggested potential roles for bupropion sustained-release (SR) and contingency management (CM), but no previous studies have assessed their combined effect. In a double-blind, placebo-controlled design, 134 adolescent smokers were randomized to receive a 6-week course of bupropion SR + CM, bupropion SR + non-CM, placebo + CM, or placebo + non-CM, with final follow-up… Expand
Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial.
TLDR
Preliminary results support the feasibility and safety of conducting adequately powered, placebo-controlled efficacy studies of varenicline and bupropion XL for adolescent smoking cessation. Expand
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia
TLDR
The results of this proof-of-concept study indicate the efficacy and feasibility of this contingency management intervention for reducing smoking in individuals with schizophrenia. Expand
Web-Based Contingency Management for Adolescent Tobacco Smokers: A Clinical Trial.
TLDR
The need for further development of contingency management therapy for adolescent smoking cessation, which emphasizes better treatment adherence and post-treatment efficacy, is underscored. Expand
Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patients.
TLDR
It will be important for future studies to evaluate participant characteristics that might predict better treatment outcome, to assess the contribution that pharmacotherapies might have alone or in combination with a CM intervention on smoking cessation and to evaluate methods for maintaining the abstinence that is achieved during this brief intervention for longer periods of time. Expand
Varenicline and Nicotine Patch Therapies in Young Adults Motivated to Quit Smoking: A Randomized, Placebo‐controlled, Prospective Study
TLDR
Varenicline may be more effective than the nicotine patch as a smoking cessation pharmacotherapy among young adult heavy smokers in the short‐term, and self‐reported smoking abstinence did not support self-reported abstinence. Expand
A Randomized Controlled Trial of Varenicline for Adolescent Smoking Cessation Specific
  • 2019
Cigarette smoking remains the leading cause of preventable death in the United States and the world. The link between smoking and cancer is clear, and cessation at a young age results in aExpand
A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.
TLDR
This is the first randomized controlled trial of pharmacotherapy for cannabis dependence in any age group to yield a positive primary cessation outcome in an intent-to-treat analysis, and findings support NAC as a pharmacotherapy to complement psychosocial treatment for Cannabis dependence in adolescents. Expand
High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trial.
TLDR
Findings do not support the use of varenicline as a first-line pharmacotherapy for smoking cessation in adolescents, and the rates of treatment-emergent adverse events were similar to those in previous trials of adult smokers, raising no new tolerability signals. Expand
Treatment of Adolescent Substance Use Disorders
TLDR
There is clearly a need to adapt or develop more effective prevention, early interventions, and treatment for youth who are “at risk,” as well as the increasing number of adolescents who have progressed to more serious substance involvement. Expand
Understanding the link between contingency management and smoking cessation: The roles of sex and self-efficacy.
TLDR
Self-efficacy was not found to mediate the relations between CM treatment and smoking cessation in the overall sample, but analyses indicated a significant moderating effect of sex on the indirect effect of treatment group on smoking cessation through self-efficism. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers.
TLDR
Despite the lack of a treatment effect, a large majority of adolescents in both treatment groups reduced their consumption to a few cigarettes per day or less and maintained this reduction over time. Expand
Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study.
TLDR
Bupropion SR along with brief counseling may be safe and potentially efficacious for adolescents with nicotine dependence with and without ADHD and smoking cessation trials in adolescents need to focus on strategies to increase retention. Expand
Contingency management for smoking cessation in adolescent smokers.
TLDR
A strong initial signal supporting the utility of CM techniques for smoking cessation in adolescents is provided and the feasibility of implementing such a program in a school setting is demonstrated. Expand
Review of bupropion for smoking cessation.
TLDR
Impressive evidence exists for the use of bupropion in smoking cessation among difficult patients who are hard-core smokers such as those with cardiovascular disease, chronic obstructive pulmonary disease (COPD) and depression. Expand
Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation.
TLDR
Sustained-release bupropion hydrochloride, 300 mg/d, plus brief counseling demonstrated short-term efficacy for adolescent smoking cessation, and abstinence rates were lower than those reported for adults, with rapid relapse after medication discontinuation. Expand
Contingency management and motivational enhancement: a randomized clinical trial for college student smokers.
  • T. Tevyaw, S. Colby, +5 authors P. Monti
  • Psychology, Medicine
  • Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
  • 2009
TLDR
Findings support the short-term efficacy of CM for reducing smoking among college students and future research should explore enhancements to CM in this population, including a longer intervention period and the recruitment of smokers who are motivated to quit. Expand
Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
TLDR
Smoking rates decreased significantly during the study, an effect that lessened at 12 weeks and 6 months, and nicotine patch therapy plus minimal behavioral intervention does not appear to be effective for treatment of adolescent smokers. Expand
Contingency management interventions for treating the substance abuse of adolescents: a feasibility study.
TLDR
Results indicated that the contingency management intervention was effective in reducing smoking, both in terms of increasing the total number of abstinences and consecutive abstInences and changes in adolescents' affective states during smoking cessation were found. Expand
Treatment of adolescent smokers with the nicotine patch.
TLDR
The results of this study suggest that the nicotine patch is a promising medication and a larger clinical trial of the nicotinePatch among adolescents is warranted. Expand
Combining cognitive behavioral therapy with contingency management for smoking cessation in adolescent smokers: a preliminary comparison of two different CBT formats.
TLDR
Preliminary results suggest that when combined with CM, the standard weekly format of CBT is more acceptable to adolescent smokers. Expand
...
1
2
3
4
5
...